<< Back Next >>
Salud Mental 2002; 25 (5)
Language: Spanish
References: 113
Page: 61-71
PDF size: 388.33 Kb.
ABSTRACT
From the first descriptions of the effects of the traumatic events of war reported by Abraham Kardiner’s in 1941; a series of studies have been carried out to describe in an exact way the chronical psychobiologic alteration that produces stress (6). With the introduction and definition of the diagnosis approaches of the posttraumatic stress disorder (PTSD) in 1980 in the DSM III (1), a series of studies that provide support to the validity of the etiology and typical phenomenology of this dysfunction have been made (3, 44, 66, 104). In the 4th. meeting of the Group of International Consent on depression and anxiety, carried out in Montecatini, Italy, in April of 1999, PTSD was considered as the most important subject due to its high prevalence, social impact, and financial burden on society. In the last 3 decades the biological guidelines of the dysfunction have begun to be established; new and effective treatments are being developed (4, 51).
PTSD is a chronic dysfunction and inability, for which so far, only partially effective treatments exist (65). A better and deeper knowledge of the psychobiological core of this dysfunction can constitute a tool of great help to liberate patients of feelings or behaviors belonging to the past (67).
The biological essence of this illness represents the long term consequences of a failure of the organism to recover from a traumatic situation, or the biological consequences that take place in answer to memories of events that are not happening in real time (111). Due to its nature, the biology of this dysfunction is different from the biology of stress, because it is a process that takes place after the stress situation is no longer physically present (81). Therefore two fundamental questions are to be made: why a failure of the organism takes place when returning to the pretraumatical state and, why some individuals recover and others don’t (111).
In the PTSD abnormal psychophysiological reactions take place at two different levels: 1). - in answer to specific memories of the traumatic event and 2). - In answer to intense but neutral stimuli, as strong noises. This indicates that people with PTSD suffer a loss in the discrimination of stimuli (6, 53).
High concentrations of suprarenal steroids have a potentially suppressive effect on the immunity system, and those stressfull events that activate the hypotalamo-hypofiso-adrenal system, can suppress certain immunitary activities (81. Many patients with chronic TPEP have physical problems and a high rate of use of the
medical services (104).
It has been demonstrated that the age at which an initial traumatic event is experienced, is a significant factor for the development of PTSD, because traumatic experiences during childhood are associated to bigger risks and more severe symptoms (12). Therefore, sexual abuse in childhood, physical abuse, or both, are linked to more victimization indexes in adults (90). Neuroimage has promoted a new focus on the neuronal filters that are involved in the interpretation of sensorial information: the interactions among the parts of the CNS that process and interpret the meaning of incoming information, just as tonsil, hippocampus, the callous body, fore cingulum and prefrontal cortex (6).
At the present time there is evidence that indicates that the disregulation of the glutamatergic, noradrenergic, and serotoninergic systems and of certain neuroendocrinal systems plays a fundamental part in this illness (65).
Threre are three aspects to handle PTSD: education, treatment and/or psychosocial support and psychopharmacological treatment (5). Health professionals in general, assume an immediate educational rol when entering in contact with patients with this dysfunction, by explaining to the victim which is the normal stress reaction to the traumatic event. Two different procedures of Behaviour Cognitive Therapy (BCT) have been commonly employed with this dysfunction: exposure and handling of anxiety (5, 42, 105). The objectives of pharmacotherapy are to reduce the symptomatology of PTSD, to reduce inability, to improve the quality of life, to improve the resistance to stress, and to reduce comorbidity (5, 18, 26, 30, 68). Well controlled data show the clinical effectiveness of SSIR in TPEP (26, 16, 18, 58, 68, 102). The FDA approved, in February 2000, sertraline’s commercialization in the treatment of the PTSD. Studies that support the effectiveness of BZD in PTSD don’t exist. On the contrary, some evidence suggests that the clinical condition of patients with PTSD deteriorates, when they are treated with BZD, there is deterioration in learning in a clinical situation; besides BZD produce annoying symptoms when supressed (18, 26, 33).
REFERENCES
AMERICAN PSYCHIATRIC ASSOCIATION: Diagnostic and Statistical Manual of Mental Disorders, Tercera edición; Washington; 1980.
AREHART-TREICHEL J: Stress More Toxic to Brain Than Reseachers Thougth. Psychiatric News, 19:2-3, 2000.
ATKINSON RM, SPARR LF, SHEFF AG: Diagnosis of posttraumatic stress disorder in Vietnam veterans: preliminary findings. Am J Psychiatry, 141:694-696, 1984.
BALLENGER J, DAVIDSON J, LECRUBIER Y. Focus on posttraumatic stress disorder. J Clin Psychiatry, 61 (supl 5): 3-12, 2000.
BALLENGER JC, DAVIDSON JRT, LECRUBIER Y, y cols.: Consensus statement on posttraumatic stress disorder from the international consensus group on depression and anxiety. J Clin Psychiatry, 61 (supl 5):60-66, 2000.
BESSEL A, VAN der KOLK: The psychobiology of posttraumatic stress disorder. J Clin Psychiatry, 58 (supl 9):16- 24, 1997.
BLANCHARD EB, KOLB LC, GERARDI RJ. Cardiac response to relevant stimuli as an adjunctive tool for diagnosing post traumatic stress disorder in Vietnam veterans. Behav Ther, 17:592-606, 1986.
BRANDON DD, KENDALL JW, ALMAN K, y cols.: Inhibition of dexamethasone binding to human glucocorticoid receptor by New World primate cell extracts. Steroids, 60: 463-466, 1995.
BRADY K, PEARLSTEIN T, ASNIS GM, y cols.: Efficacy and safety of sertraline treatment of posttraumatic stress disorder: A randomized controlled trial. JAMA, 283(14): 1837-1844, 2000.
BREMNER JD, RANDALL P, SCOTT TM, y cols.: MRIbased measure of hippocampal volume in patients with PTSD. Am J Psychiatry, 152:973-981, 1995.
BREMNER JD: Does stress damage the brain? Biol Psychiatry, 45:797-805, 1999.
BRIERE J, WOO R, McRAE B, y cols.: Lifetime victimization history , demographics, and clinical status in female psychiatric emergency room patients. J Nerv Ment Dis, 185:95-101, 1997.
BURGUESS AW, HARTMANN CR, MCCORMACK A: Abused to abuser: antecedents of socially deviant behavior. Am J Psychiatry, 144:1431-1436, 1987.
CICCHETTI D: The emergence of developmental psychopathology. Child Dev, 55:17, 1985.
COLE PM, PUTMAN FW: Effect of incest on self and social functioning: a developmental psychopathology perspective. J Consult Clin Psychol, 60:174-184, 1991.
CONNOR KM, SUTHERLAND SM, TUPLER LA, y cols.: Fluoxetine in posttraumatic stress disorder: randomized, doubleblind study. Br J Psychiatry, 175:17-22, 1999.
COOPER NA, CLUM GA: Imaginal flooding as a supplementary treatment for PTSD in combat veterans: a controlled study. Behav Ther, 20:381-391, 1989.
DAVIDSON JRT: Pharmacoteraphy of posttraumatic stress disorder: Treatment options, Long-term follow-up, and predictors of outcome. J Clin Psychiatry, 61(supl 5): 52-56, 2000.
DE BELLIS MD, BURKE L, TRICKETT PK, y cols.: Antinuclear antibodies and thyroid function in sexually abused girls. J Trauma Stress, 9:369-378, 1996.
DE BELLIS MD, LEFTER L, TRICKETT PK, y cols.: Urinary cathecolamines excretion in sexually abused girls. J Am Acad Child Adolesc Psychiatry, 33:320-327, 1994.
DEUSCHLE M, SCHWEIGER U, WEBer B, y cols.: Diurnal activity and pulsatility of the hypothalamus pituitary adrenal system in male depressed patients and healthy controls. J Clin Endocrinol Metab, 82:234-238, 1998.
DOMON SE, ANDERSON MS: Nefazodone for PTSD. J Am Acad Child Adolesc Psychiatry, 39:942-943, 2000.
EICHENBAUM H: Conscious awareness, memory and the hippocampus. Nature Neuroscience, 2(9):775-776, 2001.
FAMULARO R., KINSCHERFF R., FENTON T: Propranolol treatment for childhood posttraumatic stress disorder, acute type: A pilot study. Am J Dis Child, 142:1244-1247, 1988.
FREEMAN TW, CARDWELL D, KARSON CN, KOMOROSKI RA: In vivo proton magnetic resonance spectroscopy of medial temporal lobes of subjects with combat-related posttraumatic stress disorder. Magn Res Med, 40:66-71, 1998.
FRIEDMAN MJ: Current and future drug treatment for posttraumatic stress disorder patients. Psychiatr Ann, 28:461- 468, 1998.
FRIEDMAN MJ: What might the psychobiology of posttraumatic stress disorder teach us, about future approches to pharmacotherapy? J Clin Psychiatry, 61 (supl 7):44-51, 2000.
FRIEDMAN MJ: What might the psychobiology of posttraumatic stress disorder teach us about future approaches to pharmacotherapy? J Clin Psychiatry, 61 [supl 7]:44-51, 2000.
FOA EB, DANCU CV, HEMBREE E, y cols.: The efficacy of exposure therapy, stress inoculation training and their combination in ameliorating PTSD for female victims of assault. J Consult Clin Psychol, 67:194-200, 1999.
FOA EB, ROTHBAUM BO, RIGGS D, y cols.: Treatment of PTSD in rape victims: a comparison between cognitive behavioral procedures and counseling. J Consult Psychol, 59:715-723, 1991.
FOA EB: Psychosocial treatment of posttraumatic stress disorder. J Clin Psychiatry, 61(supl 5):43-48, 2000.
FUKATA J, USUI T, NAITOH Y, NAKAI Y, IMURA H: Effects of recombinant human interleukin 1 alpha, 1 beta, 2 and 6 on ACTH synthesis and release in the mouse pituitary tumour cell line atT20. J Endocrinol, 122:33-39, 1989.
GELPIN E, BONNE O, PERI T, y cols.: Treatment of recent trauma survivors with benzodiazepines: a prospective study. J Clin Psychiatry, 57(supl 9):390-394, 1996.
GOLDBERG J, TRUE WR, EISEN SA, HENDERSON WG: A twin study of the effect of the Vietnam war on posttraumatic stress disorder. J Am Med Assoc, 263:1227-1232, 1990.
GOULD E, TANAPAT P: Stress and hippocampal neurogenesis. Biol Psychiatry, 46: 1472-1479, 1999.
GRAY JF: The Neuropsychology of Anxiety: An Inquiry Into the Functions of the Septo-Hippocampal System. Oxford University Press, Nueva York; 1982.
GRILLON C, SOUTHWICK SM, CHARNEY DS: The psychobiological basis of posttraumatic stress disorder. Mol Psychiatry, 1:278-297, 1996.
GUPTA S, AUSTIN R, CALI LA, BHATARA V: Nightmares treated with cyproheptadina. J Am Acad Child Adolesc Psychiatry, 37:570-571, 1998.
GURVITS TV, SHENTON ME, HOKAMA H y cols.: Magnetic resonance imaging study of hippocampal volume in chronic, combat-related posttraumatic stress disorder. Biol Psychiatry, 40:1091-1099, 1996.
HAAS HS, SCHAUENSTEIN K: Neuroimmunomodulation via limbic structures: the neuroanatomy of psychoinmunology. Prog Neurobiol, 51:195-222, 1997.
HARMON RJ, RIGGS PD: Clinical perspectives: Clonidine for posttraumatic stress disorder in preschool children. J Am Acad Child Adolesc Psychiatry, 35:1247-1249, 1996.
HEMBREE EA, FOA EB: Posttraumatic stress disorder: Psychological factors and psychosocial interventions. J Clin Psychiatry, 61(supl 7):33-39, 2000.
HENNEY JE: Setraline approved for postraumatic stress disorder. JAMA, 283(5):596, 2000.
HIDALGO R, DAVIDSON J: Posttraumatic stress disorder: Epidemiology and health related considerations. J Clin Psychiatry, 61 (Supl 7) 513, 2000.
HORRIGAN JP: Guanfacine for posttraumatic stress disorder nightmares (carta). J Am Acad Child Adolesc Psychiatry, 35:975-976, 1996.
IRONSON G, WYNINGS C, SCHNEIDERMAN N y cols.: Posttraumatic stress symptoms, intrusive thoughts, loss, and immune function after Hurricane Andrew. Psychosom Med, 59:128-141, 1997.
ITO Y, TEICHER M, GLOD CA, y cols.: Increased prevalence of electrophysiological abnormalities in children with psychological, physical, and sexual abuse. J Neuropsychiatry Clin Neurosci, 5:401-408, 1993.
KARDINER A: The Traumatic Neuroses of War. Hoeber, Nueva York, 1941.
KEANE TM, FAIRBANK JA, CADDELL JM, y cols.: Implosive (Flooding) therapy reduces symptoms of PTSD in Vietnam combat veterans. Behav Ther, 20:245-260, 1989.
KOLB LC: Neurophysiological hypothesis explaining posttraumatic stress disorder. Am J Psychiatry, 144:989-995, 1987.
KORN M: New Insights into PTSD. XXIInd Congress of the Collegium Internationale NeuroPsichopharmacologicum, MEDSCAPE (www.medscape.com). 2000.
LEYBA CM, WAMPLER TP: Risperidone in PTSD [carta]. Psychiatr Serv, 49:245-246, 1998.
LITZ BT, KEANE TM: Information processing in anxiety disorders: application to the understanding of posttraumatic stress disorder. Clin Psychol Rev, 9:243-257, 1989.
LUINE V, VILEGAS M, MARTINEZ C, McEWEN BS: Repeated stress causes reversible impairments of spatial memory performance. Brain Research, 63:167-170, 1994.
MACLEOD AD: Vigabatrin and posttraumatic stress disorder [carta]. J Clin Psychopharmacol, 16:190-191, 1996.
MAES M, LIN A, DELMEIRE L y cols.: Elevated serum interleukin-6 (IL-6) and I L-6 receptor concentrations in posttraumatic stress disorder following accidental manmade traumatic events. Biol Psychiatry, 45:833-839, 1999.
MALLOY PF, FAIRBANK JA, KEANE TM: Validation of a multimethod assessment of post-traumatic stress disorders in Vietnam veterans. J Consult Clin Psychol, 51:4-21, 1983.
MARMAR CR, SCHOENFELD F, WEISS DS, y cols.: Open trial of Fluvoxamine treatment for combat-related posttraumatic stress disorder. J Clin Psychiatry, 57(supl 8):66- 70, 1996.
MARMAR CR, WEISS DS, SCHLENGER WE, y cols.: Peritraumatic dissociation and posttraumatic stress in male Vietnam theater veterans. Am J Psychiatry, 151:902-907, 1994.
McFARLANE A: The phenomenology of posttraumatic stress disorders following a natural disaster. J Nerv Ment Dis, 176:22- 29, 1988.
McFARLANE AC, WEBER DL, CLARK CR: Abnormal stimulus processing in PTSD. Biol Psychiatry, 34:311-320, 1993.
MOGHADDAM B, BOLINAO ML, STEIN–BEHRENS B, SAPOLSKY R: Glucocorticoids mediate the stress-induced extracellular accumulation of glutamate. Brain Research, 65:251-254, 1994.
MOSNAIM AD, WOLF ME, MATURANA P y cols.: In vitro studies of natural killer cell activity in post traumatic stress disorder patients. Response to methionine–enkephalin challenge. Immunopharmacology, 25:107-116, 1993.
NAVARRA P, TSAGARAKIS S, FARIA MS, REES LH, BESSER GM, GROSSMAN AB: Interleukins-1 and –6 stimulate the release of corticotropin-releasing hormone 41 from rat hypothalamus in vitro via the eicosanoid cyclooxygenase pathway. Endocrinology, 128:37-44, 1991.
NUTT DJ: The psychobiology of posttraumatic stress disorder. J Clin Psychiatry; 61 (supl 5): 24-29, 2000.
ORNITZ EM, PYNOOS RS: Startle modulation in children with posttraumatic stress disorder. Am J Psychiatry, 146:866- 870, 1989.
O’BRIEN M, NUTT D: Loss of consciousness and posttraumatic stress disorder: a cue to aetiology and treatment: Br J Psychiatry, 173:102-104, 1998.
PEARLSTEIN T: Antidepressant treatment of posttraumatic stress disorder. J Clin Psychiatry, 61(supl 7):40-43, 2000.
PERRY BD, SOUTHWICK SM, YEHUDA R, GILLER EL: Adrenergic receptor regulation in posttraumatic stress disorder. En: Giller EL (ed). Biological Assessment and Treatment of Posttraumatic Stress Disorder. American Psychiatric Press, pp 87-114, Washington, 1990.
PITMAN RK, ORR SP, FORGUE DF, y cols.: Psychophysiologic assessment of posttraumatic stress disorder imagery in Vietnam combat veterans. Arch Gen Psychiatry, 44: 970-975, 1987.
PITMAN R, ORR S, SHALEV A.: Once bitten twice shy: beyond the conditioning model of PTSD. Biol Psychiatry, 33:145-146, 1993.
PRATT WB, TOFT DO: Steroid receptor interactions with heat shock protein and immunophilin chaperones. Endocr Rev, 18:302-360, 1997.
RAINEY JM, ALEEM A, ORTIZ A y cols.: Laboratory procedure for the inducement of flashbacks. Am J Psychiatry, 144:1317-1319, 1987.
RAUCH S, Van der KOLK BA, FISLER R, y cols.: A symptom provocation study using positron emission tomography and script driven imagery. Arch Gen Psychiatry, 52:380-387, 1996.
RESICK PA, JORDAN CG, GIRELLI SA, y cols.: A comparative victim study of behavioral group therapy for sexual assault victims. Behav Ther, 19:385-401, 1988.
RESICK PA, NISHITH P, WEAVER T: Preliminary findings of a controlled trial comparing cognitive processing therapy and prolonged exposure. Presentado en el 6th European Conference on Traumatic Stress, Istanbul, Turkey, junio 1999.
RESICK PA, SCHNICKE MK: Cognitive processing therapy for sexual assault victims. J Consult Clin Psychol, 60:748- 756, 1992.
RITTER S, PELZER NL, RITTER RC: Absence of glucoprovic feeding after stress suggest impairment of noradrenergic neuron function. Brain Res, 149:399-411, 1978.
RIVIER C, VALE W, BROWN M: In the rat, interleukin-1 α y ß stimulate adrenocorticotropin and catecholamine release. Endocrinology, 125:3096-3102, 1989.
ROTHBAUM BO: A controlled study of eye movement desensitization and reprocessing in the treatment of posttraumatic stress disorder. Compr Psychiatry, 37:419-429, 1997.
SAINZ-MARTINEZ PA, GONZALEZ GP MP y cols. Bases biológicas. En: Trastorno de Estrés Postraumático, Bobes GJ, Bousoño GM, Calcedo BA, Gonzalez GP MP. pp. 35-
SAPOLSKY RM, HIDEO E, REBERT CS, y cols.: Hippocampal damage associated with prolonged glucocorticoid exposure in primates. J Neurosci, 10:2897-2902, 1990.
SAXE GN, CHINMAN G, BERKOWITZ R, y cols.: Somatization in patients with dissociative disorders. Am J Psychiatry, 151:1329-1334, 1994.
SHALEV AY, ORR SP, PERI T, y cols.: Physiologic responses to loud tones in Israeli patients with posttraumatic stress disorder. Arch Gen Psychiatry, 49:870-875, 1992.
SHALEV AY, PERI T, CANETTI L, y cols.: Predictors of PTSD in injured Trauma survivors: A prospective study. Am J Psychiatry, 153:219-225, 1996.
SHALEV AY: Post-traumatic stress disorder: diagnosis, history, and life course. En: Post traumatic Stress Disorder Diagnosis, Management and treatment. Nutt D, Davidson JRT, Zohar J (eds). Martin Dunitz Ltd, pp. 1-15. Londres, 2000.
SHAPIRO F: Eye Movement desensitization and reprocessing procedure: from EMD to EMD/R-A, new treatment model for anxiety and related trauma. Behav Ther, 5:128-133, 1991.
SHAY J: Fluoxetine reduces explosiveness and elevates mood of Vietnam combat vets with PTSD. Trauma Stress, 5:97- 101, 1992.
SHIN LM, KOSSLYN SM, McNALLY RJ, y cols.: Visual imagery and perception in posttraumatic stress disorder. Arch Gen Psychiatry, 54:233-241, 1997.
SILVA RR, ALPERT M, MUNOZ DM, y cols.: Stress and vulnerability to posttraumatic stress disorder in children and adolescents. Am J Psychiatry, 157:1229-1235, 2000.
SOLOMON Z, SINGER Y, BLUMEFIELD A: Clinical characteristics of delayed and immediate-onset combatinduced posttraumatic stress disorder. Mil Med, 160:425-430, 1995.
SOUTHWICK SM, CRISTAL JH, MORGAN A, y cols.: Abnormal noradrenergic function in post traumatic stress disorder. Arch Gen Psychiatry, 50:266-274, 1993.
SOUTHWICK SM, KRYSTAL JH, BREMENER JD y cols.: Noradrenergic and serotonergic function in posttraumatic stress disorder. Arch Gen Psychiatry, 54:749-758, 1997.
SPIVAK B, SHOHAT B, MESTER R y cols. Elevated levels of serum interleukin-1 beta in combat-related posttraumatic stress disorder. Biol Psychiatry, 42:345-348, 1997.
SQUIRE LR, ZOLA-MORGAN S.: The medial temporal lobe memory system. Science, 253:2380-2386, 1991.
STEIN MB, KOVEROLA C, HANNA C, TORCHIA MG, McCLARTY B: Hippocampal volume in women victimized by childhood sexual abuse. Psychol Med, 27:951-959, 1997.
STEIN MB: Posttraumatic Stress Disorder: a Mind’s–eye View. Presentado al 153rd Annual Meeting de la American Psychiatric Association; Chicago, 14 mayo de 2000.
TAKUYA S: The Hippocampus and Stress Related Disorders. XXIInd Congress of the Collegium Internationale Neuro-Psychopharmacologicum. MEDSCAPE. (www.medscape.com). 2000.
TEICHER M: Psychological factors in neurological development. en: Evrard P, Minkowski A (eds.) Neurobiological Development. Nestle Nutrition Workshop Series, vol 12, Raven Press, 243-258, Nueva York, 1989.
TEICHER M, GLOD CA, SURREY I y cols.: Early childhood abuse and limbic system ratings in adult psychiatric outpatients. Neuropsychiatry Clin Neurosci, 5:301-306, 1993.
TEICHER MH, ITO Y, GLOD CA, y cols.: Early abuse, limbic system dysfunction and borderline personality disorder. En: Silk K (ed.). Biological and Neurobehavioral Studies of Borderline Personality Disorder. American Psychiatric Press, 177-207, Washington, 1994.
Van der Kolk BA, Dreyfuss D, Michaels M, et al. Fluoxetine in posttraumatic stress disorder. J Clin Psychiatry, 55:517522, 1994.
Van der KOLK BA, PELCOVITZ D, ROTH S, y cols.: Dissociation, somatization, and affect dysregulation: The complexity of adaptation to trauma. Am J Psychiatry, 153 (supl 7): 83-93, 1996.
Van KAMPEN M, WATSON CG, TILLESKJOR C, y cols.: The definition of posttraumatic stress disorder in alcoholic vietnam veterans. Are the DSM-III diagnostic criteria necessary and sufficient? J Nerv Ment Dis, 174:137-144, 1986.
VERONEN LJ, KILPATRICK DG: Stress Inoculation Training for Victims of Rape: Efficacy and Differential Findings. Presentado en el 16th annual Convention of the Association for the Advancement of Behavior Therapy; Los Angeles, 1982.
WEISS JM, BAILEY J, GLAZER HI: Effects of acute exposure to stressors on subsequent avoidance escape behavior. Psychosom Med, 37:499-521, 1975.
WEISS JM, SIMSON PG, AMBROSE MJ, WEBSTER A., HOFFMAN LJ: Neurochemical basis of behavioral depression. En: Advances in Behavioral Medicine, Vol 1, Katkin E, Maunch S JAI Press, pp. 233-275, Greenwich, 1985.
YEHUDA R., LEVENGOOD RA., SCHMEIDLER J y cols.: Increased pituitary activation following metyrapone administration in posttraumatic stress disorder. J Neuroendocrinol, 21:1-16, 1996.
YEHUDA R, SOUTHWICK SM, MASON JW y cols.: Interactions of the hypothalamic pituitary adrenal axis and the catecholaminergic system of the stress disorder. En: Guiller EL (ed.). Biological Assesment and Treatment of PTSD. American Psychiatric Press, Washington, 1990.
YEHUDA R., WONG ChM: Etiology and biology of posttraumatic stress disorder. Implications for treatment. Psych Clin North Am, 8:109-134, 2001.
YEHUDA R: Biology of posttraumatic stress disorder. J Clin Psychiatry, 61 (supl 7): 14-21, 2000.
WILSON SN, Van der KOLK B, BURBRIDGE J, FISLER R, KRADIN R: Phenotype of blood lymphocytes in TEPT suggests chronic immune activation. Psychosomatics, 40:222- 225, 1999.